Pfizer Restructures Oncology and Rare Disease Units for Enhanced Focus
Company

Pfizer China Restructures Oncology and Rare Disease Units for Enhanced Focus

China's NHSA Publishes Preliminary List for 2025 National Reimbursement Drug List and Commercial Insurance Innovative Drug List
Policy / Regulatory

China’s NHSA Publishes Preliminary List for 2025 National Reimbursement Drug List and Commercial Insurance Innovative Drug List

Legend Biotech Reports Q2 Revenue Growth of 36.7% and H1 Growth of 60.4%
Company

Legend Biotech Reports Q2 Revenue Growth of 36.7% and H1 Growth of 60.4%

Takeda Reports Q1 FY2025 Revenue Dip Led by FX Headwinds and Generic Competition
Company

Takeda Reports Q1 FY2025 Revenue Dip Led by FX Headwinds and Generic Competition

Hengrui's Trastuzumab Rezetecan and Adebrelimab Granted Breakthrough Therapy Designation by China's NMPA
CompanyDrug

Hengrui’s Trastuzumab Rezetecan and Adebrelimab Granted Breakthrough Therapy Designation by China’s NMPA

Macao Drug Administration Expands White List for Designated Medical Institutions in Cooperation Zone
Policy / Regulatory

Macao Drug Administration Expands White List for Designated Medical Institutions in Cooperation Zone

CureVac and GSK Resolve mRNA Vaccine Patent Dispute With BioNTech and Pfizer
Legal / IP

CureVac and GSK Resolve mRNA Vaccine Patent Dispute With BioNTech and Pfizer

Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach
Others

Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach

Novartis Begins Shipping Next-Gen Anti-VEGF Drug Beovu for Diabetic Macular Edema
CompanyDrug

Novartis Begins Shipping Next-Gen Anti-VEGF Drug Beovu for Diabetic Macular Edema

Arvinas and Pfizer's Vepdegestrant NDA Accepted by FDA for ER+/HER2- Breast Cancer
CompanyDrug

Arvinas and Pfizer’s Vepdegestrant NDA Accepted by FDA for ER+/HER2- Breast Cancer

J&J MedTech Gains China Approval for MENTOR MemoryGel Xtra Breast Implants
CompanyMedical Device

J&J MedTech Gains China Approval for MENTOR MemoryGel Xtra Breast Implants

Mabwell Initiates U.S. Clinical Study of 9MW2821 for Triple-Negative Breast Cancer
CompanyDrug

Mabwell Initiates U.S. Clinical Study of 9MW2821 for Triple-Negative Breast Cancer